X
Xuan Wang-Kan
Researcher at University of Birmingham
Publications - 7
Citations - 627
Xuan Wang-Kan is an academic researcher from University of Birmingham. The author has contributed to research in topics: Efflux & Chemistry. The author has an hindex of 4, co-authored 6 publications receiving 381 citations. Previous affiliations of Xuan Wang-Kan include Ludwig Institute for Cancer Research.
Papers
More filters
Journal ArticleDOI
Multidrug efflux pumps: structure, function and regulation
Dijun Du,Xuan Wang-Kan,Arthur Neuberger,Hendrik W. van Veen,Klaas M. Pos,Laura J. V. Piddock,Ben F. Luisi +6 more
TL;DR: Recent advances that have increased understanding of the structures and molecular mechanisms of multidrug efflux pumps in bacteria are described, suggesting opportunities for countering their activities.
Journal ArticleDOI
Lack of AcrB Efflux Function Confers Loss of Virulence on Salmonella enterica Serovar Typhimurium
Xuan Wang-Kan,Jessica M A Blair,Barbara Chirullo,Jonathan W. Betts,Roberto M. La Ragione,Alasdair Ivens,Vito Ricci,Timothy J. Opperman,Laura J. V. Piddock +8 more
TL;DR: Loss of AcrB efflux function causes loss of virulence in Salmonella enterica serovar Typhimurium and the data suggest that gene deletion mutants are unsuitable for studying membrane transporters and, importantly, that inhibitors of AcRB Efflux function will not induce expression of other RND pumps.
Journal ArticleDOI
Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB.
Eamonn Reading,Zainab Ahdash,Chiara Fais,Vito Ricci,Xuan Wang-Kan,Elizabeth M Grimsey,Jack W Stone,Giuliano Malloci,Andy M. Lau,Heather E. Findlay,Albert Konijnenberg,Paula J. Booth,Paolo Ruggerone,Attilio Vittorio Vargiu,Laura J. V. Piddock,Argyris Politis +15 more
TL;DR: It is shown that an efflux pump inhibitor potentiates antibiotic activity by restraining drug-binding pocket dynamics, rather than preventing antibiotic binding, and it is revealed that a drug- binding pocket substitution discovered within a multidrug resistant clinical isolate modifies the plasticity of the transport pathway, which could explain its altered substrate efflux.
Journal ArticleDOI
Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1
Ruoshi Peng,C. Wang,Xuan Wang-Kan,Manja Idorn,Majken Kjaer,Felix Zhou,Berthe Katrine Fiil,Frederik Timmermann,Susana Orozco,Julia McCarthy,Carol S. Leung,Xin Lu,Katrin Bagola,Jan Rehwinkel,Andrew Oberst,Jonathan Maelfait,Søren R. Paludan,Mads Gyrd-Hansen +17 more
TL;DR: A ZBP1-RIPK3- RIPK1-mediated inflammatory signaling pathway relayed by the scaffolding role of RIPKs and regulated by caspases is described, which may induce inflammation when Z BP1 is activated below the threshold needed to trigger a cell death response.
Journal ArticleDOI
Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium
Xuan Wang-Kan,Giovanny Rodriguez-Blanco,Andrew D. Southam,Catherine L. Winder,Warwick B. Dunn,Alasdair Ivens,Laura J. V. Piddock +6 more
TL;DR: In this article, the authors analyzed the native substrate profile of AcrB in Escherichia coli MG1655 and Salmonella enterica serovar Typhimurium SL1344 using an untargeted metabolomics approach.